Annual Current Liabilities
$8.77 M
-$3.90 M-30.78%
December 31, 2023
Summary
- As of February 28, 2025, TLIS annual total current liabilities is $8.77 million, with the most recent change of -$3.90 million (-30.78%) on December 31, 2023.
- During the last 3 years, TLIS annual current liabilities has fallen by -$7.26 million (-45.28%).
- TLIS annual current liabilities is now -54.09% below its all-time high of $19.11 million, reached on December 31, 2021.
Performance
TLIS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$8.20 M
-$1.27 M-13.46%
June 30, 2024
Summary
- As of February 28, 2025, TLIS quarterly total current liabilities is $8.20 million, with the most recent change of -$1.27 million (-13.46%) on June 30, 2024.
- Over the past year, TLIS quarterly current liabilities has dropped by -$1.07 million (-11.51%).
- TLIS quarterly current liabilities is now -88.72% below its all-time high of $72.63 million, reached on June 30, 2021.
Performance
TLIS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
TLIS Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.8% | -11.5% |
| 3 y3 years | -45.3% | -35.3% |
| 5 y5 years | +160.4% | -35.3% |
TLIS Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.1% | at low | -57.1% | at low |
| 5 y | 5-year | -54.1% | +117.3% | -88.7% | +103.0% |
| alltime | all time | -54.1% | +160.4% | -88.7% | +103.0% |
Talis Biomedical Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $8.20 M(-13.5%) |
| Mar 2024 | - | $9.47 M(+8.0%) |
| Dec 2023 | $8.77 M(-30.8%) | $8.77 M(+3.8%) |
| Sep 2023 | - | $8.45 M(-8.8%) |
| Jun 2023 | - | $9.26 M(-17.2%) |
| Mar 2023 | - | $11.18 M(-11.8%) |
| Dec 2022 | $12.67 M | $12.67 M(+11.4%) |
| Sep 2022 | - | $11.38 M(-18.2%) |
| Jun 2022 | - | $13.90 M(-9.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $15.28 M(-20.0%) |
| Dec 2021 | $19.11 M(+19.2%) | $19.11 M(-39.0%) |
| Sep 2021 | - | $31.34 M(-56.8%) |
| Jun 2021 | - | $72.63 M(+55.0%) |
| Mar 2021 | - | $46.85 M(+192.2%) |
| Dec 2020 | $16.03 M(+297.1%) | $16.03 M(+16.9%) |
| Sep 2020 | - | $13.72 M(+239.8%) |
| Dec 2019 | $4.04 M(+19.9%) | $4.04 M |
| Dec 2018 | $3.37 M | - |
FAQ
- What is Talis Biomedical annual total current liabilities?
- What is the all time high annual current liabilities for Talis Biomedical?
- What is Talis Biomedical annual current liabilities year-on-year change?
- What is Talis Biomedical quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Talis Biomedical?
- What is Talis Biomedical quarterly current liabilities year-on-year change?
What is Talis Biomedical annual total current liabilities?
The current annual current liabilities of TLIS is $8.77 M
What is the all time high annual current liabilities for Talis Biomedical?
Talis Biomedical all-time high annual total current liabilities is $19.11 M
What is Talis Biomedical annual current liabilities year-on-year change?
Over the past year, TLIS annual total current liabilities has changed by -$3.90 M (-30.78%)
What is Talis Biomedical quarterly total current liabilities?
The current quarterly current liabilities of TLIS is $8.20 M
What is the all time high quarterly current liabilities for Talis Biomedical?
Talis Biomedical all-time high quarterly total current liabilities is $72.63 M
What is Talis Biomedical quarterly current liabilities year-on-year change?
Over the past year, TLIS quarterly total current liabilities has changed by -$1.07 M (-11.51%)